167 related articles for article (PubMed ID: 7639337)
21. [Cancer immunotherapy by murine bladder cancer cells transfected with mouse interferon-gamma gene].
Hashimura T; Hiura M; Yoshida O; Teramura Y; Kuribayashi K; Watanabe Y
Hinyokika Kiyo; 1993 Dec; 39(12):1205-8. PubMed ID: 8285171
[TBL] [Abstract][Full Text] [Related]
22. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
[TBL] [Abstract][Full Text] [Related]
25. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
[TBL] [Abstract][Full Text] [Related]
27. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
Zhang Y; Yao W; Zeng Z; Wang X; Sun D; Ka W; Zhou S; He D; Wen Z; Chien S
Microcirculation; 2007 Feb; 14(2):155-66. PubMed ID: 17365670
[TBL] [Abstract][Full Text] [Related]
28. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
[TBL] [Abstract][Full Text] [Related]
29. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
DiCicco LM; Truitt GA; Wheelock EF
Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
[TBL] [Abstract][Full Text] [Related]
30. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
Hiroishi K; Tüting T; Tahara H; Lotze MT
Gene Ther; 1999 Dec; 6(12):1988-94. PubMed ID: 10637450
[TBL] [Abstract][Full Text] [Related]
31. Interferon-alpha as angiogenesis inhibitor: learning from tumor models.
Indraccolo S
Autoimmunity; 2010 Apr; 43(3):244-7. PubMed ID: 20166871
[TBL] [Abstract][Full Text] [Related]
32. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice.
Deguchi Y; Kehrl JH
Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351
[TBL] [Abstract][Full Text] [Related]
33. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K
Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200
[TBL] [Abstract][Full Text] [Related]
34. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
Gresser I; Maury C; Bandu MT; Belardelli F
Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
[TBL] [Abstract][Full Text] [Related]
35. Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
[TBL] [Abstract][Full Text] [Related]
37. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.
Dinney CP; Bielenberg DR; Perrotte P; Reich R; Eve BY; Bucana CD; Fidler IJ
Cancer Res; 1998 Feb; 58(4):808-14. PubMed ID: 9485039
[TBL] [Abstract][Full Text] [Related]
39. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of antitumor immunity by IL-12 gene-transfected AK-5 tumor cells in vivo.
Nandakumar KS; Lakshmi Rao K; Pardhasaradhi BV; Khar A
Cytokines Cell Mol Ther; 1999 Mar; 5(1):7-14. PubMed ID: 10390075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]